{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:31:53Z","timestamp":1791153113106,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/aog.0000000000000356","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T23:09:55Z","timestamp":1404860995000},"page":"292-299","source":"Crossref","is-referenced-by-count":164,"title":["Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland"],"prefix":"10.1097","volume":"124","author":[{"given":"Tuuli","family":"Soini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"Hurskainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seija","family":"Gr\u00e9nman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"M\u00e4enp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorma","family":"Paavonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Pukkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-13-20210126","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.maturitas.2008.12.018","article-title":"Progestogen deficiency and endometrial cancer risk.","volume":"62","author":"Schindler","year":"2009","journal-title":"Maturitas"},{"key":"R3-13-20210126","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2013.11.010","article-title":"Tracking progesterone receptor-mediated actions in breast cancer.","volume":"142","author":"Knutson","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"suppl","key":"R4-13-20210126","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.contraception.2007.01.015","article-title":"Endometrial effects of intrauterine levonorgestrel.","volume":"75","author":"Guttinger","year":"2007","journal-title":"Contraception"},{"key":"R5-13-20210126","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/AOG.0b013e31828cb563","article-title":"Prediction of regression and relapse of endometrial hyperplasia with conservative therapy.","volume":"121","author":"Gallos","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R6-13-20210126","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/ijc.25762","article-title":"Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study.","volume":"128","author":"Jaakkola","year":"2011","journal-title":"Int J Cancer"},{"key":"R7-13-20210126","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ijc.24738","article-title":"A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well.","volume":"126","author":"Lyytinen","year":"2010","journal-title":"Int J Cancer"},{"key":"R8-13-20210126","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","article-title":". Use of the levonorgestrel-releasing intrauterine system and breast cancer.","volume":"106","author":"Backman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R9-13-20210126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.contraception.2010.11.009","article-title":"Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer.","volume":"83","author":"Dinger","year":"2011","journal-title":"Contraception"},{"key":"R10-13-20210126","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/02841869409098430","article-title":"Data quality and quality control of a population-based cancer registry. Experience in Finland.","volume":"33","author":"Teppo","year":"1994","journal-title":"Acta Oncol"},{"key":"R11-13-20210126","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10654-006-9019-8","article-title":"25-year trends and socio-demographic differences in response rates: Finnish adult health behaviour survey.","volume":"21","author":"Tolonen","year":"2006","journal-title":"Eur J Epidemiol"},{"key":"R12-13-20210126","first-page":"15","article-title":"Accuracy of data on diagnoses, procedures and accidents in the Finnish hospital discharge register.","volume":"2","author":"Keskimaki","year":"1991","journal-title":"Int J Health Sci"},{"key":"R13-13-20210126","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1403494812456637","article-title":"Quality of the Finnish hospital discharge register: a systematic review.","volume":"40","author":"Sund","year":"2012","journal-title":"Scand J Public Health"},{"key":"R16-13-20210126","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.annepidem.2007.11.011","article-title":"Meta-analysis of intrauterine device use and risk of endometrial cancer.","volume":"18","author":"Beining","year":"2008","journal-title":"Ann Epidemiol"},{"key":"R17-13-20210126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tem.2011.01.005","article-title":"Progesterone: the ultimate endometrial tumor suppressor.","volume":"22","author":"Yang","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"R19-13-20210126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/07853899009147248","article-title":"Levonorgestrel-releasing intrauterine device.","volume":"22","author":"Luukkainen","year":"1990","journal-title":"Ann Med"},{"key":"R20-13-20210126","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1093\/humrep\/del264","article-title":"The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected womeneffects on bleeding patterns, ovarian function and genital shedding of HIV.","volume":"21","author":"Heikinheimo","year":"2006","journal-title":"Hum Reprod"},{"key":"R21-13-20210126","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/humrep\/deh650","article-title":"The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up.","volume":"20","author":"Lockhat","year":"2005","journal-title":"Hum Reprod"},{"key":"R22-13-20210126","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00006254-197211000-00001","article-title":"Factors in the causation and incidence of ovarian cancer.","volume":"27","author":"Fathalla","year":"1972","journal-title":"Obstet Gynecol Surv"},{"key":"R23-13-20210126","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours.","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"key":"R24-13-20210126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00404-008-0871-5","article-title":"Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.","volume":"280","author":"Tasci","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"R25-13-20210126","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(00)03615-1","article-title":". Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.","volume":"357","author":"Hurskainen","year":"2001","journal-title":"Lancet"},{"key":"R26-13-20210126","first-page":"364","article-title":"Pancreas: a sex steroid-dependent tissue.","volume":"3","author":"Robles-Diaz","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"R27-13-20210126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1053\/j.seminoncol.2013.12.009","article-title":"Estrongenic steroid hormones in lung cancer.","volume":"41","author":"Siegfried","year":"2014","journal-title":"Semin Oncol"},{"key":"R28-13-20210126","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/aje\/kwt154","article-title":". Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS.","volume":"178","author":"Lee","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R29-13-20210126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-59745-423-0_5","article-title":"Biobanks and registers in epidemiologic research on cancer.","volume":"675","author":"Pukkala","year":"2011","journal-title":"Methods Mol Biol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000000356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:18:16Z","timestamp":1620944296000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201408000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000356","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}